Announcements Trials

Browse Landscape

Status

Sponsor Class

Study Type

Interventional 8 Observational 1

Sponsor

Cancer Type

Conditions

Sezary Syndrome 1

Interventions

Rituximab 29 Surveys and Questionnaires 25 Blood Specimen Collection 17 Gene Expression Profiling 15 Flow Cytometry 14 Polymerase Chain Reaction 13 Amplified Fragment Length Polymorphism Analysis 13 Microarray Analysis 11 Observation 10 Interviews as Topic 10 Psychiatric Rehabilitation 9 Lenalidomide 9 Immunohistochemistry 9 Cytogenetic Analysis 9 obinutuzumab 8 Watchful Waiting 8 Therapeutics 8 ibrutinib 7 Drug Therapy 7 Cyclophosphamide 7 Bendamustine Hydrochloride 7 Vincristine 6 Prednisone 6 Magnetic Resonance Spectroscopy 6 fludarabine 5 In Situ Hybridization, Fluorescence 5 Immunologic Techniques 5 Data Collection 5 Biopsy 5 zanubrutinib 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Observational × Methoxsalen × Lymphoid × Clear all

NCT05157581 2025-12-30

ECP

University of Pittsburgh

Sezary Syndrome

Data powered by HemOnc (CC BY 4.0) Colophon ⚡